Solid Biosciences Inc. — Director's Dealing 2022

Jan 5, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2022-01-03

Reporting Person: SMITH IAN F (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-03	Director Stock Option (Right to Buy)	$1.78	A	194500	Acquired	2032-01-03	Common Stock (194500)	Direct
2022-01-03	Restricted Stock Units	$	A	97250	Acquired		Common Stock (97250)	Direct

Footnotes

F1: This option was granted on January 3, 2022 pursuant to a services agreement between the reporting person and the Issuer and will vest in equal quarterly installments beginning three
months from the date of the grant, with the final installment vesting 12 months from the date of the grant, subject to continued service as a director, and in the event of a change in
control, the vesting schedule of the option will accelerate in full.

F2: Each restricted stock unit represents a contingent right to receive one share of the Issuers common stock.

F3: The restricted stock units were granted on January 3, 2022 and vest on the same schedule as set forth in footnote (1) above.